Zobrazeno 1 - 10
of 430
pro vyhledávání: '"LAURI E. MARKOWITZ"'
Autor:
Ruth Stefanos, Rayleen M. Lewis, Troy D. Querec, Julia W. Gargano, Elizabeth R. Unger, Lauri E. Markowitz
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTHuman papillomavirus (HPV) causes cervical as well as other cancers. Racial and ethnic disparities in cervical cancer incidence and mortality in the United States are well documented. HPV vaccination has been recommended in the United States
Externí odkaz:
https://doaj.org/article/62ff273db71d4854a01578c2ae178415
Autor:
Nancy McClung, Anikie Mathoma, Julia W. Gargano, Naledi Gape Nyepetsi, Troy D. Querec, Juanita Onyekwuluje, Madisa Mine, Chelsea Morroni, Rebecca Luckett, Lauri E. Markowitz, Doreen Ramogola-Masire
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Introduction In 2015, Botswana introduced quadrivalent human papillomavirus (HPV) vaccine for girls aged 9–13 years. To establish a baseline HPV prevalence for future HPV vaccine impact monitoring, we evaluated HPV prevalences among the yo
Externí odkaz:
https://doaj.org/article/cfe0cdbf228d4bb3b05f8d09dc6d6a01
Autor:
Raiza Amiling, Rachel L. Winer, Michael E. Newcomb, Pamina M. Gorbach, John Lin, Richard A. Crosby, Brian Mustanski, Lauri E. Markowitz, Elissa Meites
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5407-5412 (2021)
Gay, bisexual, and other men who have sex with men (MSM) and transgender women are disproportionately affected by human papillomavirus (HPV). HPV vaccination is routinely recommended for U.S. adolescents at age 11–12 years, with catch-up vaccinatio
Externí odkaz:
https://doaj.org/article/c9510485563848bebee4b5239ab06159
Autor:
Allison M. Brady, Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, Gitika Panicker
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 8, Pp 1802-1807 (2020)
The quadrivalent HPV vaccine (4vHPV) was originally recommended as a three-dose series (0/2/6 months), though delays in completing the series frequently occur. We previously found delayed dosing in girls resulted in similar or higher antibody titers
Externí odkaz:
https://doaj.org/article/8ce2fbe062d34c059468668ed49ab06a
Autor:
Tanja Y. Walker, Laurie D. Elam-Evans, Charnetta L. Williams, Benjamin Fredua, David Yankey, Lauri E. Markowitz, Shannon Stokley
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 3, Pp 554-561 (2020)
Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were observed in the 2016 and 2017 National Immunization Survey – Teen (NIS-Teen). In 2017, HPV vaccination initiation (≥1dose) coverage was 11 percentage point
Externí odkaz:
https://doaj.org/article/380fbdb1a62f4901865d2b9aa101b8e7
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
Gay, bisexual, and other men who have sex with men (MSM) and transgender women, particularly those who are living with HIV, are disproportionately affected by human papillomavirus (HPV). For this narrative review of HPV health outcomes and vaccinatio
Externí odkaz:
https://doaj.org/article/3eb38a0af94541db89bf99cd17ffcc56
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 7-8, Pp 1942-1948 (2019)
Estimates of medical care costs for cervical and other cancers associated with human papillomavirus (HPV) are higher in studies published in recent years than in studies published before 2012. The purpose of this report is (1) to review and summarize
Externí odkaz:
https://doaj.org/article/4598136220904a829013a035d171c1b1
Autor:
Jaimie Z. Shing, Pamela C. Hull, Yuwei Zhu, Julia W. Gargano, Lauri E. Markowitz, Angela A. Cleveland, Manideepthi Pemmaraju, Ina U. Park, Erin Whitney, Edward F. Mitchel, Marie R. Griffin
Publikováno v:
Papillomavirus Research, Vol 7, Iss , Pp 141-149 (2019)
Introduction: Evidence of human papillomavirus (HPV) vaccine impact on anogenital warts (AGWs) by race or urbanicity in the US is lacking. We evaluated HPV vaccine impact in Tennessee by assessing AGW trends among Tennessee Medicaid (TennCare) enroll
Externí odkaz:
https://doaj.org/article/a1f876a6554142eb80d69b7f9e700c6b
Autor:
Julia M.L. Brotherton, Anna R. Giuliano, Lauri E. Markowitz, Eileen F. Dunne, Gina S. Ogilvie
Publikováno v:
Papillomavirus Research, Vol 2, Iss , Pp 106-111 (2016)
In this article, we examine the issues involved if national or sub-national programs are considering extending post HPV vaccine introduction monitoring to include males. Vaccination programs are now being extended to include males in some countries,
Externí odkaz:
https://doaj.org/article/aefa19fec62740c7ba87162387145ae8
Autor:
David Mesher, Kate Soldan, Matti Lehtinen, Simon Beddows, Marc Brisson, Julia M.L. Brotherton, Eric P.F. Chow, Teresa Cummings, Mélanie Drolet, Christopher K. Fairley, Suzanne M. Garland, Jessica A. Kahn, Kimberley Kavanagh, Lauri E. Markowitz, Kevin G. Pollock, Anna Söderlund-Strand, Pam Sonnenberg, Sepehr N. Tabrizi, Clare Tanton, Elizabeth R. Unger, Sara L. Thomas
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 10, Pp 1732-1740 (2016)
We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods to consider possible changes in nonvaccine HPV genotypes after introduction of vaccines that confer protection against 2 high-risk types, HPV16 and H
Externí odkaz:
https://doaj.org/article/65c8f763ef324940a0a6f63718787f26